Retour
58
42
25
Fourchette du Jour
16,29 €
16,29 €
Fourchette 52 Semaines
16,29 €
16,29 €
Volume
100
Moyenne 50J / 200J
16,29 €
/
16,29 €
Clôture Précédente
16,29 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,1 | 0,3 |
| P/B | 0,0 | 3,0 |
| ROE % | 10,6 | 3,7 |
| Net Margin % | 2,9 | 3,8 |
| Rev Growth 5Y % | 252,9 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
243,15 €
238,36 € – 250,64 €
|
1,25T | 1 |
| FY2029 |
228,43 €
223,92 € – 235,47 €
|
1,19T | 1 |
| FY2028 |
206,21 €
202,15 € – 212,57 €
|
1,12T | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-08 | 41,79 € | 0,25 € | -99,4% |
| 2025-10-09 | 0,33 € | 0,28 € | -15,2% |
| 2025-06-23 | 0,29 € | 0,01 € | -98,1% |
| 2025-04-10 | 0,26 € | 0,24 € | -6,2% |
| 2025-01-09 | 0,27 € | 0,22 € | -17,7% |
| 2024-09-24 | 0,23 € | 0,26 € | +13,5% |
| 2024-06-25 | 0,23 € | 0,22 € | -7,2% |
| 2024-04-02 | 0,18 € | 0,21 € | +16,0% |
Dividend History
Yield
0,01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 252,94% annually over 5 years — strong growth
Earnings grew 16,88% over the past year
ROE of 10,61% — decent returns on equity
Debt/Equity of 0,18 — conservative balance sheet
Generating 10,91B in free cash flow
P/E of 0,11 — trading at a low valuation
Croissance
Revenue Growth (5Y)
252,94%
Revenue (1Y)17,94%
Earnings (1Y)16,88%
FCF Growth (3Y)841,45%
Qualité
Return on Equity
10,61%
ROIC10,78%
Net Margin2,93%
Op. Margin4,85%
Sécurité
Debt / Equity
0,18
Current Ratio1,14
Interest Coverage187,50
Valorisation
P/E Ratio
0,11
Forward P/EN/A
P/B Ratio0,01
EV/EBITDA-0,11
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17,94% | Revenue Growth (3Y) | 1238,72% |
| Earnings Growth (1Y) | 16,88% | Earnings Growth (3Y) | 1257,15% |
| Revenue Growth (5Y) | 252,94% | Earnings Growth (5Y) | 237,40% |
| Profitability | |||
| Revenue (TTM) | 878,02B | Net Income (TTM) | 25,69B |
| ROE | 10,61% | ROA | 5,19% |
| Gross Margin | 31,33% | Operating Margin | 4,85% |
| Net Margin | 2,93% | Free Cash Flow (TTM) | 10,91B |
| ROIC | 10,78% | FCF Growth (3Y) | 841,45% |
| Safety | |||
| Debt / Equity | 0,18 | Current Ratio | 1,14 |
| Interest Coverage | 187,50 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0,11 | Forward P/E | N/A |
| P/B Ratio | 0,01 | P/S Ratio | 0,00 |
| PEG Ratio | 1,02 | Forward PEG | N/A |
| EV/EBITDA | -0,11 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 369,91% | ||
| Market Cap | 2,95B | Enterprise Value | -4,49B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 878,02B | 744,48B | 4,90B | 5,44B | 5,66B |
| Net Income | 25,69B | 21,98B | 139,47M | 168,61M | 198,24M |
| EPS (Diluted) | 141,96 | 121,46 | 0,77 | 0,91 | 1,07 |
| Gross Profit | 275,04B | 228,84B | 1,49B | 1,67B | 1,70B |
| Operating Income | 42,56B | 36,62B | 232,31M | 279,46M | 319,51M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 495,12B | 390,56B | 2,59B | 2,93B | 3,27B |
| Total Liabilities | 244,41B | 157,20B | 1,00B | 1,07B | 1,38B |
| Shareholders' Equity | 250,70B | 233,36B | 1,59B | 1,86B | 1,88B |
| Total Debt | 45,35B | 837,00M | 14,34M | 20,05M | 21,88M |
| Cash & Equivalents | 52,79B | 43,43B | 254,06M | 294,19M | 524,17M |
| Current Assets | 246,48B | 199,05B | 1,47B | 1,67B | 2,01B |
| Current Liabilities | 216,08B | 136,65B | 858,66M | 891,91M | 1,21B |
Scores de Stratégies
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
#174 of 827
#243 of 618
#396 of 709
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026